Across TCGA pan-cancer cohorts, MIR181A2 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of MIR181A2’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where MIR181A2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types MIR181A2 is over-expressed in tumor.

STAD and THCA are the cancer types where MIR181A2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in MIR181A2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	Male	IV	+0.475	<.001	5	view →
THCA	All	All	+0.290	.009	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: MIR181A2 RNA expression & survival · all MIR181A2 data types